Helicobacter
Related VF: BabA (Blood group antigen binding adhesin); Flagella; Urease
Target: Not determined
Drug effect: Reduces virulence and adherence factors expression,including flaA, flaB, babB, alpA, alpB, ureE, and ureF,and inhibits urease activity.
Max phase: Preclinical (in vitro)
Publication: Xun M, et al., 2024. In vitro anti-Helicobacter pylori activity and antivirulence activity of cetylpyridinium chloride. PLoS One 19(4):e0300696.